Utang jangka cendhak marang modal Waters Corporation (WAT)

Logo grafis Waters (WAT)

Waters Corporation revenue stability is based on global analytics supplies for medicine and science. This short-term debt-to-equity chart confirms financial health, where the 0.02 mark serves as a key metric. Business resilience is ensured by R&D investments to retain top engineers and strategic component outsourcing coupled with rigorous internal quality control for instrument assembly.

Rasio utang jangka cendhak marang modal: Waters Corp. (WAT) kanggo 04.07.2022 - 31.10.2026
Produk mawa merek Waters Corp

This indicator assesses financial stability by determining the share of short-term liabilities within the equity structure. A decrease in this ratio minimizes bankruptcy risk, while an increase signals a rising debt load. By analyzing the change in the ratio of short-term borrowed capital to equity, an investor can track liquidity dynamics. For Waters Corporation (WAT), such a debt management strategy is critical when optimizing costs for production outsourcing and global logistics.

Pesaing utama

Utang jangka cendhak marang modal ABT|Utang jangka cendhak marang modal Thermo Scientific (TMO)|Utang jangka cendhak marang modal GEHC (GE HealthCare)|Tanggungan utang jangka cendhak marang ekuitas mt.com|TECH - Utang jangka cendhak marang ekuitas|BRKR (Bruker Corp) - Rasio utang jangka cendhak marang modal|Azenta Life Sciences (AZTA) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Varex Imaging Corp. (VREX)|Utang jangka cendhak marang ekuitas Semler Scientific, Inc.|butterflynetwork.com (BFLY) - Koefisien utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas MLAB (Mesa Labs)|Rasio silihan jangka cendhak marang modal QSI|Utang jangka cendhak marang modal NNOX (Nanox)|Koefisien utang jangka cendhak marang modal Quanterix Inc (QTRX)|908 Devices Inc. - Utang jangka cendhak marang modal|CapsoVision Inc (CV) - Rasio utang jangka cendhak marang ekuitas|MXCT (MaxCyte) - Rasio utang jangka cendhak marang ekuitas|Rapid Micro Biosystems, Inc. - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Seer Inc.|Rasio utang jangka cendhak marang ekuitas Hyperfine Medical (HYPR)|Utang jangka cendhak marang modal FONR|DXR - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang modal MDAI (Spectral AI, Inc.)|VIVS: Rasio utang jangka cendhak marang modal|Aclarion Corp - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal Akoya Biosciences AKYA|THMO: Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas Talis Biomedical Corporation|TTOO (T2 Biosystems) - Utang jangka cendhak marang modal